Fig. 6: IGF2BP3 exerted its tumor-promoting effects via E2F3 in EC.

A and B CCK-8 assays showed the proliferation of Ishikawa cells and HEC-1-A cells overexpressing IGF2BP3 combined with E2F3-silenced expression. C EdU assays displayed the proliferation ability of Ishikawa cells overexpressing IGF2BP3 combined with E2F3-silenced expression. D Transwell assays indicated the migration and invasion of Ishikawa cells overexpressing IGF2BP3 combined with E2F3-silenced expression. On the right side of representative images are their quantification results. *P < 0.05, **P < 0.01, ***P < 0.001, “ns”, no statistical significance. Data, mean ± S.D. All experiments were independently repeated with at least three replicates.